Who Supplies Atazanavir? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Atazanavir exports, with 17+ registered manufacturers shipping to buyers across 88+ countries — yet a handful of companies dominate the shipments. MYLAN LABORATORIES LIMITED holds the largest share at 34.0% (export value: $24.3M). Close behind, EMCURE PHARMACEUTICALS LIMITED (10.4%, $7.4M). EMCURE PHARMACEUTICALS LTD (4.9%, $3.5M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Atazanavir? Top Manufacturers & Their Buyers
Flow of Atazanavir from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Atazanavir Supplier Network — Key Market Intelligence
The Atazanavir export market from India is led by MYLAN LABORATORIES LIMITED, which alone commands a 34.0% share, shipping $24.3M worth of product across 226 shipments. The second-largest exporter, EMCURE PHARMACEUTICALS LIMITED, contributes $7.4M (10.4%) to the overall market. Combined, the top two suppliers alone account for 44.4% of all Atazanavir exports, indicating a relatively concentrated supply base.
Across all 17 tracked manufacturers, the total Atazanavir export value stands at $71.2M from 473 shipments. The market average shipment value is $150.6K. The single largest buyer relationship in terms of trade value is RWANDA MEDICAL SUPPL, receiving $16.5M worth of product.
The combined buyer network spans 15 named purchasing companies, including RWANDA MEDICAL SUPPL, MINISTRY OF HEALTH,, USAID,, COMMERCIAL BANK OF ETHIOPIA, USAID THE MISSION DIRECTOR PLOT 107 and 10 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the first-largest Atazanavir exporter from India, with a market share of 34.0% and a total export value of $24.3M across 226 shipments. Their average shipment value of $107.3K is below the market average of $150.6K, reflecting a high-volume, competitive pricing strategy.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. RWANDA MEDICAL SUPPL is the dominant customer, accounting for 67.9% of this supplier's tracked business. Top customers include:
• RWANDA MEDICAL SUPPL — $16.5M across 153 shipments (67.9% of this supplier's total exports)
• MINISTRY OF HEALTH, — $2.5M across 23 shipments (10.4% of this supplier's total exports)
• USAID, — $2.3M across 21 shipments (9.5% of this supplier's total exports)
• COMMERCIAL BANK OF ETHIOPIA — $1.7M across 16 shipments (7.1% of this supplier's total exports)
• USAID THE MISSION DIRECTOR PLOT 107 — $1.2M across 12 shipments (5.1% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED operates with high shipment frequency (226 shipments) at a per-shipment value of $107.3K, indicating a broad distribution network with many smaller, regular orders.
2EMCURE PHARMACEUTICALS LIMITED
EMCURE PHARMACEUTICALS LIMITED is the second-largest Atazanavir exporter from India, with a market share of 10.4% and a total export value of $7.4M across 159 shipments. Their average shipment value of $46.6K is below the market average of $150.6K, reflecting a high-volume, competitive pricing strategy.
EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• KENYA MEDICAL SUPPLIES AUTHORITY COMMERCIAL STREET INDUSTRIAL AREA — $2.5M across 54 shipments (33.8% of this supplier's total exports)
• ETHIOPIAN PHARMACEUTICAL SUPPLY SER — $1.8M across 38 shipments (24.2% of this supplier's total exports)
• KENYA MEDICAL SUPPLIES AUTHORITY COMMERCIAL STREET INDUSTRIAL AREA — $1.2M across 25 shipments (15.8% of this supplier's total exports)
• MINISTRY OF HEALTH AND CHILD CARE — $1.0M across 22 shipments (14.1% of this supplier's total exports)
• USAID, — $898.5K across 19 shipments (12.1% of this supplier's total exports)
Key Insight: EMCURE PHARMACEUTICALS LIMITED operates with high shipment frequency (159 shipments) at a per-shipment value of $46.6K, indicating a broad distribution network with many smaller, regular orders.
3EMCURE PHARMACEUTICALS LTD
EMCURE PHARMACEUTICALS LTD is the third-largest Atazanavir exporter from India, with a market share of 4.9% and a total export value of $3.5M across 8 shipments. Their average shipment value of $435.9K is above the market average of $150.6K, suggesting premium or bulk contract pricing.
EMCURE PHARMACEUTICALS LTD serves 5 named buyers in our database. MINISTRY OF HEALTH G is the dominant customer, accounting for 52.7% of this supplier's tracked business. Top customers include:
• MINISTRY OF HEALTH G — $1.8M across 4 shipments (52.7% of this supplier's total exports)
• KENYA MEDICAL SUPPLIES AUTHORITY COMMERCIAL STREET INDUSTRIAL AREA — $1.2M across 3 shipments (35.1% of this supplier's total exports)
• UAB LABTEKA VILKPEDE — $171.1K across 0 shipments (4.9% of this supplier's total exports)
• UNITED NATIONS OFFIC — $153.9K across 0 shipments (4.4% of this supplier's total exports)
• COSPHARM TAMPLUS DIS — $101.5K across 0 shipments (2.9% of this supplier's total exports)
Key Insight: EMCURE PHARMACEUTICALS LTD's per-shipment value of $435.9K is 189% above the market average of $150.6K, consistent with large-order contracts or value-added formulations.
4CIPLA LIMITED
CIPLA LIMITED is the fourth-largest Atazanavir exporter from India, with a market share of 3.3% and a total export value of $2.3M across 8 shipments. Their average shipment value of $293.5K is above the market average of $150.6K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 3 named buyers in our database. MEDPRO PHARMACEUTICA (PTY) LTD, is the dominant customer, accounting for 95.9% of this supplier's tracked business. Top customers include:
• MEDPRO PHARMACEUTICA (PTY) LTD, — $2.3M across 8 shipments (95.9% of this supplier's total exports)
• MEDPRO PHARMACEUTICA (PTY) LTD, — $68.8K across 0 shipments (2.9% of this supplier's total exports)
• MEDPRO PHARMACEUTICA (PTY) LTD, — $26.3K across 0 shipments (1.1% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $293.5K is 95% above the market average of $150.6K, consistent with large-order contracts or value-added formulations.
5HETERO LABS LIMITED
HETERO LABS LIMITED is the fifth-largest Atazanavir exporter from India, with a market share of 0.9% and a total export value of $637.9K across 43 shipments. Their average shipment value of $14.8K is below the market average of $150.6K, reflecting a high-volume, competitive pricing strategy.
HETERO LABS LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF — $296.7K across 20 shipments (46.5% of this supplier's total exports)
• TO THE ORDER OF — $190.0K across 13 shipments (29.8% of this supplier's total exports)
• TO THE ORDER — $151.0K across 10 shipments (23.7% of this supplier's total exports)
• MAKIZ PHARMA LIMITED — $191 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: HETERO LABS LIMITED operates with high shipment frequency (43 shipments) at a per-shipment value of $14.8K, indicating a broad distribution network with many smaller, regular orders.
6MACLEODS PHARMACEUTICALS LIMITED
MACLEODS PHARMACEUTICALS LIMITED is the fifth-largest Atazanavir exporter from India, with a market share of 0.5% and a total export value of $369.0K across 3 shipments. Their average shipment value of $123.0K is below the market average of $150.6K, reflecting a high-volume, competitive pricing strategy.
MACLEODS PHARMACEUTICALS LIMITED serves 1 named buyer in our database. NORDIC PHARMACEUTICA is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• NORDIC PHARMACEUTICA — $369.0K across 3 shipments (100.0% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LIMITED operates with high shipment frequency (3 shipments) at a per-shipment value of $123.0K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Atazanavir Flows
Once Atazanavir leaves the manufacturing plants of companies like MYLAN LABORATORIES LIMITED and EMCURE PHARMACEUTICALS LIMITED, it travels to 5 destination markets with a combined import value of $71.2M. Rwanda absorbs the largest share at 23.2% ($16.5M), followed by Tanzania (11.2%) and Kenya (10.3%).
This geographic spread reflects Atazanavir's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Atazanavir Go? Top Importing Countries & Their Buyers
Trade flow of Atazanavir exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Rwanda
Rwanda ranks as the first-largest destination for Atazanavir imports from India, with a total trade value of $16.5M across 0 shipments — representing a 23.2% share of all Atazanavir exports. The average shipment value of $16.5M is above the global average of $150.6K, indicating high-value procurement contracts or branded formulations.
Key Insight: Rwanda's per-shipment average of $16.5M (10866% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Rwanda is a key market for Atazanavir imports from India.
2Tanzania
Tanzania ranks as the second-largest destination for Atazanavir imports from India, with a total trade value of $8.0M across 5 shipments — representing a 11.2% share of all Atazanavir exports. The average shipment value of $1.6M is above the global average of $150.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Atazanavir importers in Tanzania: EMBASSY OF THE UNITED STATES OF AME is the largest buyer, accounting for 35.8% ($2.9M) of this market's total imports.
• EMBASSY OF THE UNITED STATES OF AME — $2.9M (35.8% of Tanzania's total)
• MINISTRY OF HEALTH, — $2.5M (31.5% of Tanzania's total)
Key Insight: Tanzania's per-shipment average of $1.6M (964% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Tanzania is a key market for Atazanavir imports from India.
3Kenya
Kenya ranks as the third-largest destination for Atazanavir imports from India, with a total trade value of $7.4M across 13 shipments — representing a 10.3% share of all Atazanavir exports. The average shipment value of $565.6K is above the global average of $150.6K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Atazanavir importers in Kenya: KENYA MEDICAL SUPPLIES AUTHORITY is the largest buyer, accounting for 38.3% ($2.8M) of this market's total imports.
• KENYA MEDICAL SUPPLIES AUTHORITY — $2.8M (38.3% of Kenya's total)
• KENYA MEDICAL SUPPLIES AUTHORITY COMMERCIAL STREET INDUSTRIAL AREA — $2.4M (32.5% of Kenya's total)
• NATIONAL MEDICAL STORES — $1.0M (13.8% of Kenya's total)
Key Insight: Kenya's per-shipment average of $565.6K (276% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Kenya is a key market for Atazanavir imports from India.
4Nigeria
Nigeria ranks as the fourth-largest destination for Atazanavir imports from India, with a total trade value of $4.4M across 26 shipments — representing a 6.2% share of all Atazanavir exports. The average shipment value of $170.6K is above the global average of $150.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Atazanavir importers in Nigeria: USAID, is the largest buyer, accounting for 51.7% ($2.3M) of this market's total imports.
• USAID, — $2.3M (51.7% of Nigeria's total)
• USAID THE MISSION DIRECTOR PLOT 107 — $1.2M (28.0% of Nigeria's total)
Key Insight: Nigeria's per-shipment average of $170.6K (13% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Nigeria is a key market for Atazanavir imports from India.
5Ethiopia
Ethiopia ranks as the fifth-largest destination for Atazanavir imports from India, with a total trade value of $4.3M across 8 shipments — representing a 6.0% share of all Atazanavir exports. The average shipment value of $534.4K is above the global average of $150.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Atazanavir importers in Ethiopia: ETHIOPIAN PHARMACEUTICAL SUPPLY SER is the largest buyer, accounting for 41.9% ($1.8M) of this market's total imports.
• ETHIOPIAN PHARMACEUTICAL SUPPLY SER — $1.8M (41.9% of Ethiopia's total)
• COMMERCIAL BANK OF ETHIOPIA — $1.7M (40.4% of Ethiopia's total)
Key Insight: Ethiopia's per-shipment average of $534.4K (255% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ethiopia is a key market for Atazanavir imports from India.
People Also Ask — Atazanavir Supplier & Trade Network
Who are the top suppliers of Atazanavir from India?+
Which companies buy Atazanavir from Indian manufacturers?+
Where does Atazanavir exported from India go?+
What is the market share of the top Atazanavir supplier from India?+
What is the average shipment value for Atazanavir exports from India?+
Is Atazanavir manufactured in India and exported globally?+
Which country imports the most Atazanavir from India?+
Who are the buyers of Atazanavir in Tanzania?+
How concentrated is the Atazanavir supplier market in India?+
How do I find verified buyers for Atazanavir in specific countries?+
Atazanavir Trade Network — Key Takeaways
- 1MYLAN LABORATORIES LIMITED is India's dominant Atazanavir exporter with a 34.0% market share and $24.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 17 suppliers collectively account for 54.1% of all tracked Atazanavir exports, with a combined trade value of $71.2M.
- 3Rwanda is the largest destination market, absorbing 23.2% of India's Atazanavir exports ($16.5M). Tanzania (11.2%) and Kenya (10.3%) follow.
- 4With 473 total shipments averaging $150.6K each, the Atazanavir export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include RWANDA MEDICAL SUPPL, MINISTRY OF HEALTH,, KENYA MEDICAL SUPPLIES AUTHORITY COMMERCIAL STREET INDUSTRIAL AREA, ETHIOPIAN PHARMACEUTICAL SUPPLY SER — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 88 countries
Network value: $71.2M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Atazanavir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Atazanavir.
- 2.Flow Mapping: 17 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 473 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 88 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
473 Verified Shipments
17 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists